{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-078865","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2026-06-29T20:32:03+00:00","discovered_at":"2026-06-29T20:33:00.216424+00:00","generated_at":"2026-06-29T20:33:12.587695+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"United Therapeutics shareholders approve 2026 Stock Incentive Plan with 1.5M new shares","bullets":["Plan adds 1,500,000 new shares; total reserve includes 2,413,730 carryover from prior plan plus returning shares.","Shareholders approved plan with 25,872,075 for, 10,070,290 against (72% support); advisory say-on-pay also passed.","All 12 director nominees elected; highest vote total was Kevin Tracey with 36,187,554 for, lowest was Christopher Causey with 32,342,983.","Plan allows options, SARs, restricted stock, RSUs, stock awards, and incentive bonuses; administered by Compensation Committee.","Effective June 26, 2026; no further grants under the 2015 plan; prior awards unaffected."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-078865","json":"https://secwatch.observer/filing/0001104659-26-078865.json","markdown":"https://secwatch.observer/filing/0001104659-26-078865.md","text":"https://secwatch.observer/filing/0001104659-26-078865.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465926078865/0001104659-26-078865-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465926078865/tm2619258d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T20:33:12.587695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}